Tizanidine Tablet
Product Images NDC 70518-4181

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 70518-4181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description for a medication called Tizanidine. It is a 4 mg tablet. Each package contains 90 tablets. The manufacturer is Viena Pharmaceuticals Inc. located in Cranford, NJ. The medication should be stored at temperatures between 20-25°C (58-77°F). For detailed usage instructions, refer to the package insert. It is important to keep this medication out of the reach of children. The medication is only available with a prescription.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 01)

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 02)

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 03)

This text provides a comparison of the improvement in Ashworth Score over time following the administration of different doses of tizanidine. The chart displays results at various time points post-dose, comparing the effects of 16mg tizanidine, 8mg tizanidine, and placebo.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 04)

This text describes an improvement in the Ashworth Score using Tizanidine at a mean dose of 26.8 mg. The data includes information about the end of the titration, end of maintenance, and the study endpoint at different time points.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.